A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma

BACKGROUND: This study was performed to assess the efficacy and feasibility of definitive chemoradiotherapy consisting of weekly doses of combined paclitaxel and carboplatin concurrent with radiation therapy, followed by 2 cycles of consolidation chemotherapy for advanced esophageal carcinoma. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yi, Li, Yun-hai, Chen, Yun, Liu, Qi, Zhang, Jun-hua, Deng, Jia-ying, Ai, Ta-shan, Zhu, Han-ting, Badakhshi, Harun, Zhao, Kuai-Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951896/
https://www.ncbi.nlm.nih.gov/pubmed/29435872
http://dx.doi.org/10.1007/s10147-018-1240-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951896/
https://www.ncbi.nlm.nih.gov/pubmed/29435872
http://dx.doi.org/10.1007/s10147-018-1240-4

Ejemplares similares